SCHEMBL10065396

SCHEMBL10065396

c1ccc(-n2c3ccccc3c3cc(-c4ccc(-c5nc6c(-c7cccc8ccccc78)cccc6o5)cc4)ccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.39
KDM4E B2RXH2 5/20 0.38
ATM Q13315 2/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 7/20 0.36
HSD17B10 Q99714 4/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 3/20 0.36
GAA P10253 1/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
TP53 P04637 1/20 0.34
PTPN1 P18031 4/20 0.34
BMPR1B O00238 1/20 0.34
ACVRL1 P37023 1/20 0.34
ACVR1 Q04771 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13426824 0.94 TOP2A (0.38) TOP2AKDM4EATMSIRT2SIRT1
SCHEMBL10065367 0.92 TOP2A (0.43) TOP2AKDM4EATMSIRT2SIRT1
SCHEMBL10065225 0.91 TOP2A (0.41) TOP2AKDM4EATML3MBTL1ALDH1A1
SCHEMBL10065107 0.90 TOP2A (0.41) TOP2AKDM4EATML3MBTL1ALDH1A1
SCHEMBL10065349 0.90 TOP2A (0.38) TOP2AKDM4EATMSIRT2SIRT1
SCHEMBL13426373 0.87 TOP2A (0.39) TOP2AKDM4EATML3MBTL1ALDH1A1
SCHEMBL13426778 0.86 TOP2A (0.42) TOP2AKDM4EATMSIRT2SIRT1
SCHEMBL27049528 0.86 TOP2A (0.39) TOP2AKDM4EATMSIRT2SIRT1
SCHEMBL10065398 0.85 KDM4E (0.39) TOP2AKDM4EATMSIRT2SIRT1
SCHEMBL10065400 0.85 KDM4E (0.39) TOP2AKDM4EATMSIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 US disclosed
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative GABRA1, GABRA4, GABRA5 TOP2A 1535/4885KDM4E 3212/4885ATM 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.